Bruton's Tyrosine Kinase Inhibitors with Distinct Binding Modes Reveal Differential Functional Impact on B-Cell Receptor SignalingWei Li(AbbVie (United States)), Chih‐Hung Lee(AbbVie (United States))Molecular Cancer TherapeuticsSeptember 21, 202310.1158/1535-7163.mct-22-0642Cited by 19SaveCiteExport RISWatch citationsRelated PapersMechanistic Insights Into the Analgesic Efficacy of A-1264087, a Novel Neuronal Ca2+ Channel Blocker That Reduces Nociception in Rat Preclinical Pain Models|Journal of Pain|2013|12